COVID-19 Vaccination and Long-Term Mortality: What the Data Shows

Strong research continues to support COVID immunization status as significantly protective for overall health and longevity. Personal biases aside, the evidence reinforces vaccination campaigns as a sound public health and workforce strategy. A large study of more than 28 million adults under age 60 found that individuals who received at least one dose of a COVID-19 mRNA vaccine had lower all-cause mortality over a four-year period compared with those who were unvaccinated. After standardizing for differences between groups, all-cause mortality was 25% lower among vaccinated individuals. In addition, vaccinated adults were 74% less likely to die in a hospital from COVID-19. Overall mortality incidence was 0.4% among vaccinated individuals versus 0.6% among those unvaccinated during the study period (Semenzato et al., 2025). For employers and health plan sponsors focused on long-term risk management, the data suggest that vaccination strategies can contribute meaningfully to population health and long-term cost containment.

Semenzato, L., Le Vu, S., Botton, J., et al. (2025). COVID-19 mRNA vaccination and 4-year all-cause mortality among adults aged 18 to 59 years in France. JAMA Network Open, 8(12), e2546822. https://doi.org/10.1001/jamanetworkopen.2025.46822